Vimarsana
Biggest News Aggregation in the World

Page 22 - Oint Inflammation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oint Inflammation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oint Inflammation Today - Breaking & Trending Today

EULAR Issues Imaging Recommendations for Gout, CPPD - Vimarsana News

EULAR Issues Imaging Recommendations for Gout, CPPD

The document provides guidance on using imaging in the diagnosis and management of all common forms of crystal-induced arthropathies.

EULAR PsA Update Emphasizes Safety, Non-MSK Manifestations - Vimarsana News

EULAR PsA Update Emphasizes Safety, Non-MSK Manifestations

The update builds on 2019 recommendations and incorporates safety concerns about JAK inhibitors, advises on differential drug efficacy across disease manifestations, and eliminates systemic steroids.

Nuances in Efficacy, MACE Risk Revealed Between JAKi, TNFi - Vimarsana News

Nuances in Efficacy, MACE Risk Revealed Between JAKi, TNFi

Three studies provide more data on risk for major adverse cardiovascular events with JAK inhibitors vs TNF inhibitors, as well as their efficacy in patients with different levels of risk.

Uricase-Based Gout Drug Meets Endpoints in Phase 3 Trials - Vimarsana News

Uricase-Based Gout Drug Meets Endpoints in Phase 3 Trials

Two phase 3 trials of the once-monthly SEL-212 in refractory gout achieved and maintained serum uric acid

RA and Demyelinating Disease: No Consistent Link to TNFi - Vimarsana News

RA and Demyelinating Disease: No Consistent Link to TNFi

Patients with rheumatoid arthritis who take a tumor necrosis factor inhibitor do not appear to have a consistent and significant risk for developing a demyelinating disease.